| Dr Piyanuch Pahn Pataramekin, DO | |
|
800 Biesterfield Rd Ste 510, Elk Grove Village, IL 60007-3367 | |
| (847) 981-3660 | |
| Not Available |
| Full Name | Dr Piyanuch Pahn Pataramekin |
|---|---|
| Gender | Female |
| Speciality | Critical Care (intensivists) |
| Experience | 12 Years |
| Location | 800 Biesterfield Rd Ste 510, Elk Grove Village, Illinois |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184997314 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Presence Saint Joseph Hospital - Chicago | Chicago, IL | Hospital |
| Presence Saints Mary And Elizabeth Medical Center | Chicago, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alexian Brothers Medical Care Group Nfp | 6002134624 | 47 |
News Archive
Biovision, the annual forum devoted to future-oriented research in life sciences, today announces its program to bring a new level of awareness to the economic and business challenges faced by the life sciences industry.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the Biologics License Application (BLA) for ipilimumab for the treatment of adult patients with advanced melanoma who have been previously treated. The company also announced today that the application has been granted a priority review designation by the FDA.
Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher M.J. Al-Musawi, Newcastle University, Newcastle upon Tyne, UK, will present a study titled "In Vitro Effects of Topical Neuromodulatory Medication on Orofacial Tissue."
Having established that excessive fat tissue can fuel the growth of certain cancers, researchers have turned their attention to the molecular mechanisms involved in the process in the hopes of developing new cancer treatments.
Psilocybin, a psychedelic drug believed to help rewire the brain, is now being studied to relieve treatment-resistant depression at The University of Texas Health Science Center at Houston (UTHealth) as part of a global Phase II clinical trial.
› Verified 1 days ago
| Entity Name | Critical Care Physicians Of Illinois Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508134966 PECOS PAC ID: 7012179294 Enrollment ID: O20120504000178 |
News Archive
Biovision, the annual forum devoted to future-oriented research in life sciences, today announces its program to bring a new level of awareness to the economic and business challenges faced by the life sciences industry.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the Biologics License Application (BLA) for ipilimumab for the treatment of adult patients with advanced melanoma who have been previously treated. The company also announced today that the application has been granted a priority review designation by the FDA.
Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher M.J. Al-Musawi, Newcastle University, Newcastle upon Tyne, UK, will present a study titled "In Vitro Effects of Topical Neuromodulatory Medication on Orofacial Tissue."
Having established that excessive fat tissue can fuel the growth of certain cancers, researchers have turned their attention to the molecular mechanisms involved in the process in the hopes of developing new cancer treatments.
Psilocybin, a psychedelic drug believed to help rewire the brain, is now being studied to relieve treatment-resistant depression at The University of Texas Health Science Center at Houston (UTHealth) as part of a global Phase II clinical trial.
› Verified 1 days ago
| Entity Name | Alexian Brothers Medical Care Group Nfp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518420413 PECOS PAC ID: 6002134624 Enrollment ID: O20150410002237 |
News Archive
Biovision, the annual forum devoted to future-oriented research in life sciences, today announces its program to bring a new level of awareness to the economic and business challenges faced by the life sciences industry.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the Biologics License Application (BLA) for ipilimumab for the treatment of adult patients with advanced melanoma who have been previously treated. The company also announced today that the application has been granted a priority review designation by the FDA.
Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher M.J. Al-Musawi, Newcastle University, Newcastle upon Tyne, UK, will present a study titled "In Vitro Effects of Topical Neuromodulatory Medication on Orofacial Tissue."
Having established that excessive fat tissue can fuel the growth of certain cancers, researchers have turned their attention to the molecular mechanisms involved in the process in the hopes of developing new cancer treatments.
Psilocybin, a psychedelic drug believed to help rewire the brain, is now being studied to relieve treatment-resistant depression at The University of Texas Health Science Center at Houston (UTHealth) as part of a global Phase II clinical trial.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Piyanuch Pahn Pataramekin, DO 800 Biesterfield Rd Ste 510, Elk Grove Village, IL 60007-3367 Ph: (847) 981-3660 | Dr Piyanuch Pahn Pataramekin, DO 800 Biesterfield Rd Ste 510, Elk Grove Village, IL 60007-3367 Ph: (847) 981-3660 |
News Archive
Biovision, the annual forum devoted to future-oriented research in life sciences, today announces its program to bring a new level of awareness to the economic and business challenges faced by the life sciences industry.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the Biologics License Application (BLA) for ipilimumab for the treatment of adult patients with advanced melanoma who have been previously treated. The company also announced today that the application has been granted a priority review designation by the FDA.
Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher M.J. Al-Musawi, Newcastle University, Newcastle upon Tyne, UK, will present a study titled "In Vitro Effects of Topical Neuromodulatory Medication on Orofacial Tissue."
Having established that excessive fat tissue can fuel the growth of certain cancers, researchers have turned their attention to the molecular mechanisms involved in the process in the hopes of developing new cancer treatments.
Psilocybin, a psychedelic drug believed to help rewire the brain, is now being studied to relieve treatment-resistant depression at The University of Texas Health Science Center at Houston (UTHealth) as part of a global Phase II clinical trial.
› Verified 1 days ago
Michael James Keller, M.D. Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 800 Biesterfield Rd, Suite 510, Elk Grove Village, IL 60007 Phone: 847-981-3660 Fax: 847-956-5108 | |
Dr. Barry Glick, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 810 Biesterfield Rd, Suite 306, Elk Grove Village, IL 60007 Phone: 847-981-6061 Fax: 847-981-6062 | |
Dr. Bhupinder K Chhabra, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Biesterfield Rd, Suite 3007, Elk Grove Village, IL 60007 Phone: 847-290-6513 Fax: 847-290-8505 | |
Anshul Aggarwal, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Biesterfield Rd Ste G01, Elk Grove Village, IL 60007 Phone: 847-981-3680 | |
Edward J Diamond, M.D. Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 800 Biesterfield Rd, Suite 510, Elk Grove Village, IL 60007 Phone: 847-981-3660 Fax: 847-956-5108 | |
Anurag Mehrotra, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Biesterfield Rd Ste 510, Elk Grove Village, IL 60007 Phone: 847-981-3660 | |
Nephtali Kogan, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Biesterfield Rd Ste G01, Elk Grove Village, IL 60007 Phone: 847-981-3680 |